Full Text
HIGH COURT OF DELHI
CS(COMM) 82/2023 & I.A. 4327/2023
GSP CROP SCIENCE PVT LTD ..... Plaintiff
Through: Mr. G. Nataraj, Mr. Shashikant Yadav, Ms. Harshita Agarwal, Mr. Rahul Bhujbal and Mr. Vishal Mishra, Advs.
Through: Mr. Neeraj Yadav, Adv.for D-1
JUDGMENT
03.03.2023
1. This is an application under Order XXIII Rule 3 of the Code of Civil Procedure, 1908 (CPC), for decreeing of the suit qua Defendant 1, as the dispute between the petitioner and Defendant 1 stands settled.
2. The terms and conditions of settlement have been set out in the application, and read thus: “i. BR Agrotech i.e., Defendant No. 1 acknowledges the Plaintiff's exclusive right in dealing in products containing the formulation which is subject matter protected by the claims of Indian Patent 394568 i.e., the suit patent; ii. BR Agrotech further also acknowledges the validity of Indian Patent 394568 and acknowledges that any act of making, using, offering for sale, selling or importing, the subject matter of the claims of the suit patent, will violate the statutory rights of the Plaintiff therein; iii. BR Agrotech stipulates that it has manufactured and sold a suspo-emulsion formulation of Pyriproxyfen 5% and Diafenthiuron 25% to the following Companies as mentioned below. The details till date of the signing of this settlement are set out hereinbelow: Sale Volume (KL) Customer Brand Name 2021-22 2022-23 ATUL LIMITED CROLIS 0 8 FMC INDIA PVT LTD.
AMADIS SUPER 0 34 HERANBA INDUSTRIES LIMITED ROXYFIN 25 43 MAHINDRA STRAZER 45 12 RALLIS INDIA LIMITED BORIS 0 52 RAMCIDES CROPSCIENCE PVT.
LTD FENPROX 12 16 COROMANDEL BULK 16 Grand Total 98 KL 165 KL iv. BR Agrotech affirms that it has not manufactured or sold any product infringing the claims of IN 394568 to any other entity apart from the Companies identified above in paragraph (iii), and undertakes that during the lifetime of IN' 568 it will not infringe the rights of the Plaintiff in the claims of the suit patent in any manner, including for example, by making, using, offering for sale, selling or importing a product which falls within the scope of the claims of IN 394568; v. BR Agrotech also undertakes to inform the Plaintiff within 48 hours of any request received from any third party for supply of any product which comprises of a suspo-emulsion of Pyriproxyfen range of 1-15% and Diafenthiuron in range of 5-25% and to assist and cooperate with the Plaintiff in any enforcement action that the Plaintiff may choose to pursue against such third party; vi. BR Agrotech agrees to suffer a decree in terms of Prayer (a) of the plaint, as set out hereinbelow: "A decree of permanent injunction restraining the Defendant, their directors, employees, officers, servants, agents, subsidiaries, affiliates and all other acting for and on their behalf from making, using, selling, distributing, advertising, exporting, offering for sale, and in any other manner, directly or indirectly, dealing in any product or process that infringes the claimed subject matter of the Plaintiff's Indian Patent No. 394568 or any of the claims thereof, including any suspo-emulsion formulation of Pyriproxyfen and Diafenthiuron wherein the Pyriproxyfen is in the range of 1-15% and Diafenthiuron is in the range of 5-25%" vii. BR Agrotech undertakes to seek a license from the Plaintiff in the event it wishes in the future to manufacture or sell or carry out any other commercial activity in respect of any suspo-emulsion formulation of Pyriproxyfen 1-15% and Diafenthiuron 5-25% protected by Indian Patent 394568; viii. Plaintiff undertakes to cooperate with Defendant No. 1 i.e., BR Agrotech in the application it will move to secure release from the Hon’ble Court of the original material including any documents etc., seized during the raid conducted on its premises in New Delhi on 20.02.2023; ix. Subject to the undertakings and statements given by the parties herein, the Plaintiff waives its claim for delivery up, damages, rendition of accounts and costs of the proceedings as regards the Defendant No. 1; x. Parties agree and undertake that above undertakings and statements shall be binding henceforth on the parties as appropriate, as well as their respective associates, representatives, successors, partners, employees, affiliates and assignees-inbusiness.”
3. As such, no dispute survives between the plaintiff and Defendant 1 as would require consideration by the court.
4. Learned Counsel for the plaintiff and Defendant 1 are present and agree, on behalf of their respective clients, to abide by the aforesaid terms of settlement.
5. Accordingly, the suit stands decreed qua Defendant 1 in terms of the terms of settlement reproduced hereinabove.
6. Let a decree sheet be drawn up by the Registry accordingly.
7. This application stands allowed.
C. HARI SHANKAR, J.
MARCH 3, 2023